Human fibronectin is synthesized as a pre-propolypeptide  by Gutman, Alejandro et al.
Volume 207, number 1 FEBS 4113 October 1986 
Human fibronectin is synthesized as a pre-propolypeptide 
Alejandro Gutman, Kenneth M. Yamada+ and Albert0 Kornblihtt” 
Institute de Investigaciones n Ingenieria Genktica y Biologia Molecular (INGEBI-CONICET), Vuelta de Obrigado 2490, 
1428 Buenos Aires, Argentina and ‘Laboratory of Molecular Biology, National Cancer Institute, NIH, Bethesda, 
MD 20892, USA 
Received 9 July 1986; revised version received 25 August 1986 
Fibronectins (FNs) are ~xtracellufar glycoproteins consisting of dimers or multimers of similar but not 
identical subunits. The subunit differences result from variations in internal primary sequence due to alter- 
native splicing in at least 2 regions of the pre-mRNA. The complete amino acid sequence of mature human 
cellular FN has been reported recently from cDNA cloning and sequencing. The same approach has now 
enabled us to deduce, for the first time, that FN has a 26 amino acid signal peptide and that it undergoes 
proteolytic processing at its N-terminus to eliminate a 5 amino acid pro-sequence (Ser-Lys-Ser-Lys-Arg). 
The signal sequence matches the consensus format, while this pro-sequence is a distinctive, very hydrophilic 
and basic peptide. 
(Human) Fibronectin Signalpeptiak Pro-peptide cDNA 
1. INTRODUCTION 
Fibronectin (FN) represents a family of very 
closely related glycoproteins found in blood 
plasma and on cell surfaces. FN is involved in a 
wide variety of cell-cell and cell-substrate pro- 
cesses, including cell attachment and spreading, 
cell migration during embryogenesis, opsoniza- 
tion, oncogenic transformation and wound heal- 
ing. This biological versatility is due to the 
co-existence, in the same protein, of binding sites 
for collagen, fibrin, heparin, bacteria, DNA and 
cell surfaces [l-3]. 
Two major forms of FN have been identified: a 
plasma form which is a soluble heterodimer and a 
cellular form which consists of dimers or highly in- 
soluble multimers. The two forms contain 
disulfide-linked subunits taken from a pool of 
similar but not identical polypeptides. All possible 
subunits are produced by a single gene [4], and 
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their primary structural differences are the results 
of a complex pattern of alternative splicing in at 
least two regions of the primary transcript termed 
ED and IIICS [5-121. 
Recently, the complete primary structure of 
mature human FN has been determined by sequen- 
cing a series of overlapping cDNA clones [ 111. 
Although the literature on partial peptide sequenc- 
ing of FN is very extensive, no data are available 
on the N-terminal amino acid sequence of in vitro 
translated FN to show the existence of a prepro- 
FN. We report here the isolation and sequencing of 
cDNA clones that demonstrate the presence of 
signal and pro-peptides in human FN. 
2. MATERIALS AND METHODS 
2.1. RNA preparation 
Human cell line Hs578T [13] was cultured in 
Dulbecco’s modified Eagle medium containing 
10% fetal calf serum. Total RNA was extracted 
from confluent cell monolayers by the guanidine- 
HCI method [14]. Poly(A)+ RNA was obtained by 
chromatography on oligo-dT cellulose [ 151. 
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2.2. cDNA cloning 2.4. SI mapping 
Isolation of clone pFH6 by ‘mRNA walking’ has 
been described [ 111. An oligonucleotide primer 
(3 ’ -CGAGTCGTTTACCAAGTCG-5 ’ ) comple- 
mentary to the mRNA region close to the 5 ’ -end of 
pFH6 was synthesized by the phosphotriester 
method [16]. The oligonucleotide was used to 
prime reverse transcription of poly(A)+ RNA from 
Hs578T cells. Blunt-ended ds cDNA was prepared 
by the RNase H method [17] and cloned into 
pAT153/Pvu 11/8 [18]. Colonies were screened us- 
ing as probe a 27 bp HindIII-DdeI restriction frag- 
ment from the 5 ’ -end of pFH6 (fig. l), labelled by 
filling-in at the Hind111 end. Whatman 541 paper 
replicas were obtained [19] and hybridized with the 
probe in 5 x SSC, 1% SDS, 1 x Denhardt’s solu- 
tion, lOOpg/ml herring sperm DNA, at 45°C over- 
night. After washing with 5 x SSC, 0.1% SDS at 
25”C, two independent clones, pFH 2 and pFH 3, 
were obtained. 
S1 nuclease mapping was performed as follows: 
a 501 bp TaqI fragment from pFH3 was labelled 
with [y-32P]ATP and polynucleotide kinase after 
dephosphorylation with calf intestinal phos- 
phatase. The probe was hybridized to 25 pg of 
Hs578T total RNA in formamide at 54°C. 
Hybridization and subsequent steps were as 
described [5]. 
3. RESULTS 
Fig.1 shows the organization of clones pFH2 
and pFH3. These cDNA clones were constructed 
with a synthetic primer complementary to the 
5 ’ -end of a previously isolated clone, pFH6, which 
reached the N-terminus of mature FN. Primer ex- 
tension experiments (not shown) using the same 
primer showed that the sequences of hFN mRNA 
upstream of those coding for the N-terminal 
glutamine of FN [21,22] should be no longer than 
380 bases. The insert of clone pFH2 corresponds to 
the first 119 bases of the 5 ‘-sequences. Clone 
pFH3 has a 258 bp insert beginning, as did the 
pFH2 insert, with the primer sequence. However, 
the furthest upstream 139 bp of the pFH3 insert do 
2.3. DNA sequencing 
It was performed by the chemical degradation 
procedure [20]. 
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Probe 
I 4 
,Prlmer , 
- 
mRNA CAP+tn260b/ / 7600bases +A, 
pFH 2 
Fig. 1. Localization of the inserts of clones pFH6, pFH2 and pFH3 along FN mRNA. Wavy lines are vector sequences. 
B = BumHI; H = Z%ndIII. (*) Region encoding the predicted cleavage site for signal peptidase. (0) Region encoding 
the cleavage site between pro- and mature FN. pFH3 contains 139 bp of FN-unrelated DNA due to a cloning artifact 
(dotted empty box). 
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Fig.2. Nucleotide sequence and deduced amino acid sequence of human FN cDNA clone pFH2. DNA: sequence 
complementary to the primer and TaqI site used in Sr mapping (fig.3) are underlined. Protein: the processing ‘window’ 
is shown by slashes. (*) Predicted cleavage site for signal peptidase. (0) Cleavage site between pro- and mature FN. 
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Fig.3. Sr nuclease analysis of Hs578T cell total 
RNA/cDNA hybrids. The probe was the 501 bp TaqI 
fragment of pFH3 carrying 222 bp of insert sequences 
upstream of the labelled site (n) plus 279 bp of 
vector sequences (-). + and - indicate presence 
and absence of Hs578T cell RNA in the hybridization 
mixture, respectively. 
not seem to correspond to FN mRNA, as shown by 
the Si mapping experiment in fig.3. Only the 
downstream 84 bp of the probe remained Si resis- 
tant after hybridization with the same RNA used 
for the construction of the clones. Furthermore, 
the upstream 139 bp of clone pFH3 failed to 
hybridize to FN mRNA in ‘Northern blots’ (not 
shown). We then concluded that, as an artifact of 
cloning, a piece of DNA unrelated to FN co-ligated 
with FN cDNA in pFH3. 
Fig.2 shows the amino acid sequence deduced 
from the nucleotide sequence of clone pFH2. A 
stretch of 3 1 amino acids preceding the N-terminal 
glutamine of hFN could be recognized as leader 
and pro-sequences. Although no protein data exist 
for comparison, these sequences must belong to 
FN based on the following evidence. First, there is 
a 35 bp overlap between pFH2 and pFH6. Second, 
the leader sequence present in the Tag1 probe is 
totally protected in Si mapping (fig.3) and third, a 
nucleotide sequence identical to the one shown in 
fig.2 was read when sequencing directly single- 
stranded cDNA bands obtained by reverse 
transcription using the 19-mer oligonucleotide 
(section 2.2) as primer (not shown). 
4. DISCUSSION 
Fibronectin is an extracellular glycoprotein, and 
would thus be expected to have a signal peptide. 
Our data confirm this prediction but also show the 
existence of a pro-peptide. Amino acid 31 in fig.2 
should be the carboxy end of a pro-peptide but not 
of a signal peptide: first, with the sole exception of 
apolipoprotein Al [23], all reported pro-peptides 
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end in a pair of basic amino acids (in our case K 
at 30 and R at 3 1). Second, signal peptides normal- 
ly end in amino acids with small, uncharged side 
chains [24]. Our data do not prove that the ATG 
coding for M no.1 in fig.2 is necessarily the 
initiation codon. However, the presence of an A 
and a C three and one nucleotides upstream from 
the ATG, respectively, is consistent with the con- 
sensus sequence reported by Kozak [25] around 
functional initiator codons. Assuming that thic 
ATG is the initiator triplet, we applied the criteris 
described by Von Heijne [26] to calculate the ‘pro- 
cessing probability’, and predicted the point of 
cleavage for signal peptidase between amino acids 
26 and 27, within a ‘processing window’ spanning 
amino acids 20-27. The FN signal therefore fits 
the consensus format in its length (26 residues) and 
hydrophobicity, including a charged residue within 
the first five amino acids (R at 3), followed by a 
core of hydrophobic residues (amino acids 9-14, 
17,20 and 21) and ending with a small, uncharged 
residue (A at 26). The subsequent predicted pro- 
peptide SKSKR is very hydrophilic and basic; it 
was not present in any other protein in the NBRF 
protein databank. We have previously de- 
monstrated that FN does not undergo proteolytic 
processing at the C-terminus [4]. The existence of 
a predicted pro-peptide indicates that FN 
undergoes more post-translational proteolysis at 
its N-terminus, than signal elimination; the func- 
tion of this novel charged domain in FN processing 
remains to be determined. 
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